Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfang Guan

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Journal of Gastrointestinal Oncology|November 19, 2020
Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancerWei Zhao, Lige Qiu, Huajiang Liu, et al.
The Oncologist|April 28, 2018
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic ProfileHelei Hou, Hua Zhu, Han Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 8, 2024
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomasJianwei Zhang, Hanxiao Chen, Junli Zhang, et al.
Cancer Letters|December 16, 2014
RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencingXueda Hu, Shengqing Wan, Ying Ou, et al.
American Journal of Translational Research|November 19, 2019
The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinomaYan An, Yanfang Guan, Yaping Xu, et al.
Plos One|August 8, 2012
Simultaneous detection and identification of enteric viruses by PCR-mass assayJingzi Piao, Jun Jiang, Bianli Xu, et al.
Oncogene|December 4, 2020
Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinomaXuewen Liu, Fang Wang, Chunwei Xu, et al.
International Journal of Cancer|June 27, 2019
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancerFei Ma, Yanfang Guan, Zongbi Yi, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective StudyNi Jiang, Guoliang Qiao, Xiaoli Wang, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Journal of Gastrointestinal Oncology|November 19, 2020
Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancerWei Zhao, Lige Qiu, Huajiang Liu, et al.
The Oncologist|April 28, 2018
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic ProfileHelei Hou, Hua Zhu, Han Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 8, 2024
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomasJianwei Zhang, Hanxiao Chen, Junli Zhang, et al.
Cancer Letters|December 16, 2014
RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencingXueda Hu, Shengqing Wan, Ying Ou, et al.
American Journal of Translational Research|November 19, 2019
The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinomaYan An, Yanfang Guan, Yaping Xu, et al.
Plos One|August 8, 2012
Simultaneous detection and identification of enteric viruses by PCR-mass assayJingzi Piao, Jun Jiang, Bianli Xu, et al.
Oncogene|December 4, 2020
Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinomaXuewen Liu, Fang Wang, Chunwei Xu, et al.
International Journal of Cancer|June 27, 2019
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancerFei Ma, Yanfang Guan, Zongbi Yi, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective StudyNi Jiang, Guoliang Qiao, Xiaoli Wang, et al.
Pageof 13